Alzheimer's Progression Monitoring Device

Alzheimer’s Progression Monitoring involves tracking the changes in key biomarkers and cognitive function over time to assess the stage and rate of disease advancement. Using advanced biosensors, MEMS technology, and AI-driven analysis, this process enables early detection of Alzheimer’s-related biomarkers like beta-amyloid and tau proteins in cerebrospinal fluid (CSF).

A reliable monitoring system helps:

• Detect disease progression early for timely intervention.

• Personalize treatment plans based on real-time biomarker analysis.

• Reduce reliance on invasive procedures while maintaining accuracy.

• Empower patients and caregivers with actionable insights into disease management.

By integrating non-invasive diagnostics, AI-powered analysis, and precision biosensing, Alzheimer’s Progression Monitoring aims to improve patient outcomes and quality of life.